Key result
Probucol significantly decreased the left ventricle/body weight ratio and improved endothelium-dependent relaxations in a swine model of left ventricular hypertrophy.
Why the study?
Does probucol improve endothelial dysfunction and limit left ventricular hypertrophy in a swine model of aortic banding?
Does probucol improve endothelial dysfunction and limit left ventricular hypertrophy in a swine model of aortic banding?
In a swine model of aortic banding, the antioxidant probucol limited the development and induced regression of left ventricular hypertrophy and associated coronary endothelial dysfunction.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in swine LVH; leaves open translation to human endothelial function or hypertrophy.
The lipid-lowering agent probucol may be efficacious, through its antioxidant properties, to limit and reverse the vascular endothelial dysfunction associated with left ventricular hypertrophy (LVH). LVH was induced by performing an aortic banding (AB) on swine, except for controls (group 1). The untreated AB group received a placebo (group 2) whereas the treated groups received probucol (1000 mg/d orally); the third group began its treatment on the day of the banding (for 60 d), the fourth began on day 30 and the fifth on day 60 after AB (both for 30 d). Hypertrophy was assessed by echocardiography and histology. Coronary vascular reactivity was evaluated in organ chambers and endothelial function by quantification of NO2/NO3 and cyclic guanosine-3',5'-monophosphate. To assess oxidative stress, hydroperoxides and angiotensin II levels as well as superoxide dismutase activity were evaluated. After treatment with probucol, a significant decrease in left ventricle/body weight ratio was observed compared with the untreated group. Dose-response curves of the probucol groups showed an improvement in endothelium-dependent relaxations, associated with increased nitric oxide bioavailability and decreased angiotensin II and hydroperoxide levels. In conclusion, the antioxidant probucol limited the development and induced the regression of LVH and the associated coronary endothelial dysfunction.
No takes yet. Share an insight, caveat, or question.
Aubin et al. (2006) studied Left ventricular hypertrophy. Probucol vs. Placebo was evaluated on Left ventricle/body weight ratio and endothelium-dependent relaxations. Probucol significantly decreased the left ventricle/body weight ratio and improved endothelium-dependent relaxations in a swine model of left ventricular hypertrophy.
Synapse has enriched 10 related papers. Consider them for comparative context: